Chemistry, 13.02.2020 21:42 jacobbrandon2002

The concentration of acetylsalicylic acid, C9H8O4, in aspirin tablets is determined by hydrolyzing it to the salicylate ion, C7H5O3-, and determining its concentration spectrofluorometrically. A stock standard solution is prepared by weighing 0.0774 g of salicylic acid, C7H6O3, into a 1-L volumetric flask and diluting to volume. A set of calibration standards is prepared by pipeting 0, 2.00, 4.00, 6.00, 8.00, and 10.00 mL of the stock solution
into separate 100-mL volumetric flasks that contain 2.00 mL of 4 M NaOH and diluting to volume. Fluorescence is measured at an emission wavelength of 400 nm using an excitation wavelength of 310 nm with
results shown in the following table.

Several aspirin tablets are ground to a fine powder in a mortar and pestle. A 0.1013-g portion of the powder is placed in a 1-L volumetric flask and diluted to volume with distilled water. A portion of this solution is filtered to remove insoluble binders and a 10.00-mL aliquot transferred to a 100-mL volumetric flask that contains 2.00 mL of 4 M NaOH. After diluting to volume the fluorescence of the resulting solution is 8.69. What is the %w/w acetylsalicylic acid in the aspirin tablets?

Answers: 1

Show answers

Answers

Answer from: Quest

under a microscope, cancer cells may look very different from normal cells. they often have different sizes and some may be larger than normal while others are smaller. cancer cells are often abnormally shaped and the control centre of the cell (the nucleus) may have an abnormal appearance.

i think? ?

Answer from: Quest

Answers are 1,2,4 its correct on edgenuity.

Answer from: Quest

Answerthis solution will not form a precipitateexplanationsolubility equilbrium: pbf₂(s) ⇄ pb²⁺(aq) + 2 f⁻(aq)the solubility product expression is $k_{sp} = [\text{pb}^{2+}][\text{f}^- ]^2 = 4 \times 10^{-8}$ (we exclude solids from the equilibrium expression).now suppose we have the trial ion product q, which we can define as $q = [\text{pb}^{2+}]_{\text{initial}} \cdot [\text{f}^- ]^2_{\text{initial}}$ then, we can interpret q as the product of the concentration of the ions that we have and ksp as the product of the ion concentrations that are needed to form a saturated solution.if q > ksp, then that implies that there will be a surplus of ions that exceed the amount that is required to form a saturated solution. a precipitate will then form (the precipitate continually forms until the surplus ions are removed and q is decreased to ksp's value).if q = ksp, the saturated solution that forms is barely saturated and the precipitate will be minimal.if q < ksp, then the ion concentration will not be enough to form a saturated solution (so no precipitate).using our information, we calculate the trial ion product: $\begin{aligned} q & = [\text{pb}^{2+}]_{\text{initial}} \cdot [\text{f}^- ]^2_{\text{initial}} \\ & = (1.9 \times 10^{-3} ) (3.8\times 10^{3})^2 \\ & = 2.7 \times 10^{-8} \end{aligned}$ since q = 2.7 × 10⁻⁸ < ksp = 4 × 10⁻⁸, a precipitate will not form.

Answer from: Quest

answer is: empirical formula is tl₂o. if we use 100 grams of compound, tha:

m(tl) = 96.2% · 100 g ÷ 100%.

m(tl) = 96.2 g.

n(tl) = m(tl) ÷ m(tl). n(tl) = 96.2 g ÷ 204.4 g/mol.

n(tl) = 0.47 mol. m(o) = 3.77 g. n(o) = m(o) ÷ m(o). n(o) = 3.77 g ÷ 16 g/mol. n(ag) = 0.235 mol. n(tl) . n(o) = 0.47 mol : 0.235 mol /0.235. n(tl) . n(o) = 2 : 1.

m(tl₂o) = 204.4 g/mol · 2 + 16 g/mol = 424.8 g/mol.

m(compound) = 456. 8 g/mol - 424.8 g/mol = 32 g/mol ( 2 oxygens); tl₂o₃.